• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡聚糖-甲泼尼龙琥珀酸酯作为甲泼尼龙的前药:对大鼠血液和脾脏淋巴细胞的体外免疫抑制作用

Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: in vitro immunosuppressive effects on rat blood and spleen lymphocytes.

作者信息

Rensberger K L, Hoganson D A, Mehvar R

机构信息

Department of Biology, Drake University, Des Moines, IA 50311, USA.

出版信息

Int J Pharm. 2000 Oct 10;207(1-2):71-6. doi: 10.1016/s0378-5173(00)00544-5.

DOI:10.1016/s0378-5173(00)00544-5
PMID:11036232
Abstract

The in vitro immunosuppressive activity of a conjugate of methylprednisolone (MP) with dextran 70 kDa (DEX-MPS) was tested using the lymphocyte proliferation assay after stimulation of lymphocytes with concanavalin A (Con-A). Blood and spleen lymphocytes, isolated from drug-free male Sprague-Dawley rats, were used in the assay. First, the optimum concentration of Con-A for stimulation of lymphocytes was determined. The inhibition of the lymphocyte proliferation was then tested in the presence of 0.25,0.5, 1.0,2.5,5.0,10,20, and 50 nM concentrations (MP equivalent) of DEX-MPS or free MP. The maximum stimulation of lymphocytes with Con-A was observed at mitogen concentrations of 2.5 and 10 microg/ml for the spleen and blood lymphocytes, respectively. For free MP, sigmoidal relationships were observed between the effect (% inhibition of lymphocyte proliferation) and the logarithm of MP concentration. Additionally, the maximum inhibitory effect (I(max)) and MP concentration producing half of I(max) (IC(50)) were, respectively, 98% and 1.38 nM for the blood and 86% and 3.1 nM for the spleen lymphocytes. For MP conjugated to dextran, the response-log concentration curves were substantially shifted to the right with IC(50) values of 40 and 52 nM for the blood and spleen lymphocytes, respectively. It is concluded that compared with free MP, the steroid attached to dextran has minimal immunosuppressive activity. Therefore, to be effective in vivo, DEX-MPS should release MP in the body.

摘要

使用伴刀豆球蛋白A(Con-A)刺激淋巴细胞后,通过淋巴细胞增殖试验检测甲基强的松龙(MP)与70 kDa葡聚糖(DEX-MPS)缀合物的体外免疫抑制活性。从无药物的雄性Sprague-Dawley大鼠分离的血液和脾脏淋巴细胞用于该试验。首先,确定刺激淋巴细胞的Con-A的最佳浓度。然后在存在0.25、0.5、1.0、2.5、5.0、10、20和50 nM浓度(MP当量)的DEX-MPS或游离MP的情况下测试淋巴细胞增殖的抑制作用。对于脾脏和血液淋巴细胞,分别在2.5和10 μg/ml的促细胞分裂剂浓度下观察到Con-A对淋巴细胞的最大刺激。对于游离MP,在效应(淋巴细胞增殖抑制百分比)与MP浓度的对数之间观察到S形关系。此外,血液淋巴细胞的最大抑制作用(I(max))和产生I(max)一半的MP浓度(IC(50))分别为98%和1.38 nM,脾脏淋巴细胞分别为86%和3.1 nM。对于与葡聚糖缀合的MP,响应-对数浓度曲线显著向右移动,血液和脾脏淋巴细胞的IC(50)值分别为40和52 nM。得出的结论是,与游离MP相比,附着在葡聚糖上的类固醇具有最小的免疫抑制活性。因此,为了在体内有效,DEX-MPS应在体内释放MP。

相似文献

1
Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: in vitro immunosuppressive effects on rat blood and spleen lymphocytes.葡聚糖-甲泼尼龙琥珀酸酯作为甲泼尼龙的前药:对大鼠血液和脾脏淋巴细胞的体外免疫抑制作用
Int J Pharm. 2000 Oct 10;207(1-2):71-6. doi: 10.1016/s0378-5173(00)00544-5.
2
Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats.葡聚糖-甲泼尼龙琥珀酸酯作为甲泼尼龙的前药:对大鼠体内给药后的免疫抑制作用。
Pharm Res. 2000 Nov;17(11):1402-7. doi: 10.1023/a:1007555107691.
3
Hepatic immunosuppressive effects of systemically administered novel dextran-methylprednisolone prodrugs with peptide linkers in rats.新型肽连接的葡聚糖-甲泼尼龙前药在大鼠体内的系统给药的肝免疫抑制作用。
J Pharm Sci. 2012 Oct;101(10):4003-12. doi: 10.1002/jps.23274. Epub 2012 Jul 24.
4
Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: local immunosuppressive effects in liver after systemic administration to rats.葡聚糖-甲泼尼龙琥珀酸酯作为甲泼尼龙的前体药物:大鼠全身给药后在肝脏中的局部免疫抑制作用
Pharm Res. 2003 Feb;20(2):198-204. doi: 10.1023/a:1022358702643.
5
Immunodynamics of methylprednisolone induced T-cell trafficking and deactivation using whole blood lymphocyte proliferation techniques in the rat.
Biopharm Drug Dispos. 1999 Jul;20(5):255-61. doi: 10.1002/(sici)1099-081x(199907)20:5<255::aid-bdd183>3.0.co;2-e.
6
Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes.甲基泼尼松龙的大分子前药琥珀酸葡聚糖 - 甲基泼尼松龙在大鼠血液和肝溶酶体中的水解动力学。
J Control Release. 2000 Jul 31;68(1):53-61. doi: 10.1016/s0168-3659(00)00234-0.
7
Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: plasma and tissue disposition.葡聚糖-甲泼尼龙琥珀酸酯作为甲泼尼龙的前体药物:血浆和组织分布
J Pharm Sci. 2001 Dec;90(12):2078-87. doi: 10.1002/jps.1158.
8
Plasma pharmacokinetics and tissue disposition of novel dextran-methylprednisolone conjugates with peptide linkers in rats.新型带有肽键连接物的葡聚糖-甲泼尼龙缀合物在大鼠体内的血浆药代动力学和组织分布。
J Pharm Sci. 2010 Mar;99(3):1626-37. doi: 10.1002/jps.21934.
9
Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: dose-dependent pharmacokinetics in rats.右旋糖酐-甲泼尼龙琥珀酸钠作为甲泼尼龙的前药:大鼠体内的剂量依赖性药代动力学
Int J Pharm. 2001 Oct 23;229(1-2):173-82. doi: 10.1016/s0378-5173(01)00854-7.
10
Development of a macromolecular prodrug of FK 506: II: In vitro study for FK 506-dextran conjugate.FK 506大分子前药的研发:II:FK 506-葡聚糖缀合物的体外研究
Transplant Proc. 1998 Jun;30(4):1031-2. doi: 10.1016/s0041-1345(98)00138-9.

引用本文的文献

1
In vitro and in vivo evaluation of microparticulate drug delivery systems composed of macromolecular prodrugs.由大分子前药组成的微粒药物递送系统的体外和体内评价
Molecules. 2008 Aug 10;13(9):2136-55. doi: 10.3390/molecules13092136.
2
Synthesis and in vitro characterization of novel dextran-methylprednisolone conjugates with peptide linkers: effects of linker length on hydrolytic and enzymatic release of methylprednisolone and its peptidyl intermediates.新型带有肽接头的葡聚糖-甲基泼尼松龙缀合物的合成及体外表征:接头长度对甲基泼尼松龙及其肽基中间体水解和酶促释放的影响
J Pharm Sci. 2008 Jul;97(7):2649-64. doi: 10.1002/jps.21161.
3
Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: local immunosuppressive effects in liver after systemic administration to rats.
葡聚糖-甲泼尼龙琥珀酸酯作为甲泼尼龙的前体药物:大鼠全身给药后在肝脏中的局部免疫抑制作用
Pharm Res. 2003 Feb;20(2):198-204. doi: 10.1023/a:1022358702643.